10 presentations were found matching your search word(s) with International Session(Panel Discussion)

International Session (Panel Discussion)1 (JSGE, JGES, JSH, JSGS)

October 31, 9:30–12:00, Room 9 (Portopia Hotel Main Building Kairaku 3)

Molecular based precision medicine in gastroenterology

Time Slot for Each Speaker: (Time slots vary depending on presentations. Please prepare your presentation as below.)
  IS-PD1-Keynote Lecture1, IS-PD1-Keynote Lecture2 : 20 min. for oral presentation
  Other Presentations: 10 min. for oral presentation, 0 min. for Q&A
Discussion: After all presentations
Introductory Meeting: Not to be held
  • Chairperson:
    Shin MaedaDepartment of Gastroenterology, Yokohama City University Hospital
  • Chairperson:
    Taro TakamiDepartment of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine

IS-PD1-Keynote Lecture1
Blood-based biomarkers in gastrointestinal cancers

Ajay Goel Beckman Research Institute of the City of Hope

IS-PD1-Keynote Lecture2
The role of gut microbiome in cirrhosis

Jimmy Che-To Lai The Chinese University of Hong Kong

IS-PD1-1_G
PARD6B Deficiency Disrupts Gut Homeostasis and Drives Inflammatory Bowel Disease Progression

Keiko Maeda Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine

IS-PD1-2_G
Genomic Landscape and Prognostic Role of Homologous Recombination Repair Gene Mutations in Small Bowel Adenocarcinoma

Yoshiyasu Kono Department of Gastroenterology and Hepatology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University

IS-PD1-3_G
Investigation of the mechanism of duodenal cancer progression using a novel mouse model

Makoto Sugimori Division of Cancer Genome Medicine, Yokohama City University Medical Center,Gastroenterological Center, Yokohama City University Medical Center

IS-PD1-4_G
Multiregional genomic analysis of intraepithelial or superficial spreading extrahepatic bile duct cancer elucidated by minute dissection and deep sequencing

Yusuke Kouchi Department of Molecular Pathology, Chiba University Graduate School of Medicine

IS-PD1-5_G
Clinical outcome of patients with gBRCA1/2 mutation-positive unresectable pancreatic cancer: a multicenter prospective study

Tomohiro Kubo Department of Medical Oncology and Hematology, Sapporo Medical University School of Medicine

IS-PD1-6_G
Efficacy of measuring natural killer-activating receptor ligands to predict the pathogenesis of metabolic dysfunction-associated steatotic liver disease

Jun Arai Department of Gastroenterology, Aichi Medical University

IS-PD1-7_H
TEAD Inhibition as a Therapeutic Strategy for Chronic Liver Disease

Yoshinobu Saito The University of Osaka Graduate School of Medicine Department of Gastroenterology and Hepatology

IS-PD1-8_H
Investigation of the impact of LG2m on the tumor immune microenvironment and the efficacy of cancer immunotherapy in hepatocellular carcinoma

Kouki Nio Innovative Clinical Research Center, Kanazawa University Hospital

Page Top

Page Top